These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8229762)

  • 1. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
    Levier DG; Brown RD; McCay JA; Fuchs BA; Harris LS; Munson AE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):357-63. PubMed ID: 8229762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of morphine and naltrexone on the antibody response in various mouse strains.
    Bussiere JL; Adler MW; Rogers TJ; Eisenstein TK
    Immunopharmacol Immunotoxicol; 1992; 14(3):657-73. PubMed ID: 1517538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment.
    Bryant HU; Bernton EW; Kenner JR; Holaday JW
    Endocrinology; 1991 Jun; 128(6):3253-8. PubMed ID: 2036988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of methadone on the immune status of B6C3F1 mice.
    LeVier DG; Brown RD; Musgrove DL; Butterworth LF; McCay JA; White KL; Fuchs BA; Harris LS; Munson AE
    Fundam Appl Toxicol; 1995 Feb; 24(2):275-84. PubMed ID: 7737438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
    Carr DJ; Gerak LR; France CP
    J Pharmacol Exp Ther; 1994 May; 269(2):693-8. PubMed ID: 8182537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):81-8. PubMed ID: 8474033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine pellet-induced immunomodulation in mice: temporal relationships.
    Bryant HU; Bernton EW; Holaday JW
    J Pharmacol Exp Ther; 1988 Jun; 245(3):913-20. PubMed ID: 3385646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors.
    Fuchs BA; Pruett SB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):417-23. PubMed ID: 8392561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of azathioprine on phagocytic activity and morphology of reticulo-endothelial organs in mice.
    Gotjamanos T
    Pathology; 1971 Jul; 3(3):171-9. PubMed ID: 4107198
    [No Abstract]   [Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen.
    Lux F; Han YH; Brase DA; Dewey WL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):688-93. PubMed ID: 2732944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat.
    Yoburn BC; Cohen AH; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Apr; 237(1):126-30. PubMed ID: 3958962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change in the absorptive capacity of macrophages from different organs after administration of hydrocortisone].
    Maianskiĭ DN; Voronina NP; Voronin AIu
    Biull Eksp Biol Med; 1985 Sep; 100(9):324-6. PubMed ID: 4041600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma corticosteroid levels in rats maintained on a long-acting naltrexone delivery system.
    Misra AL; Pontani RB; Vadlamani NL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):43-50. PubMed ID: 663407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous morphine produces more tolerance than intermittent or acute treatment.
    Dighe SV; Madia PA; Sirohi S; Yoburn BC
    Pharmacol Biochem Behav; 2009 May; 92(3):537-42. PubMed ID: 19248799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxicological profile of morphine sulfate in B6C3F1 female mice.
    LeVier DG; McCay JA; Stern ML; Harris LS; Page D; Brown RD; Musgrove DL; Butterworth LF; White KL; Munson AE
    Fundam Appl Toxicol; 1994 May; 22(4):525-42. PubMed ID: 8056200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
    Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
    Bryant HU; Roudebush RE
    J Pharmacol Exp Ther; 1990 Nov; 255(2):410-4. PubMed ID: 2243332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.